Greece took delivery of 200,000 antibody tests from US medical device developer Abbott Laboratories on Thursday.
Abbott’s system, which has already been used in reference labs, hospitals and academic medical centers, was touted last week by University of Washington researchers in a study published in the Journal of Clinical Microbiology. The study, according to the researchers, showed that the antibody test for the Coronavirus strain COVID-19 “demonstrates excellent analytical performance.”
US Ambassador Geoffrey Pyatt told Greek Health Minister Vassilis Kikilias that the delivery will help Greece through the next phase of battling the virus.
“This is a commercial purchase, but it required significant coordination between the Ministry and Abbott, and the Embassy was pleased to help facilitate this. We hope this delivery of these tests will aid Greece through this critical next phase of battling the virus and restarting the Greek economy,” Pyatt said in remarks during the meeting.
“As Greek businesses begin to open up the economy again… and as we look towards the summer tourism season, we agree on the importance of accurate testing so that our officials and our scientists can continue to make informed decisions about the public health and safety aspects of this period of the Coronavirus crisis,” Pyatt stated.
See all the latest news from Greece and the world at Greekreporter.com. Contact our newsroom to report an update or send your story, photos and videos. Follow GR on Google News and subscribe here to our daily email!
